2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO2] Mini-Oral Session 2　Hepatobiliary / Pancreatic Cancer 1（Pancreatic Cancer 1）
【E】

Thu. Feb 17, 2022 8:30 AM - 9:20 AM Room 5 (Room B-1, 2F, Kyoto International Conference Center)

Chair：Kumiko Umemoto（Department of Clinical Oncology, St. Marianna University School of Medicine ），Takeshi Terashima（Department of Gastroenterology, Kanazawa University Hospital）

[MO2-3] Nal-IRI+5-FU/LV vs 5-FU/LV in metastatic pancreatic cancer-Additional safety report of randomized Japanese phase 2 trial

○Masafumi Ikeda1, Tatsuya Ioka2, Makoto Ueno3, Takuji Okusaka4, Zhaoyang Teng5, Momoko Furuya6, Junji Furuse7 (1.Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, 2.Oncology Center, Yamaguchi University Hospital, 3.Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, 4.Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, 5.Biometrics Department, Servier Pharmaceuticals LLC, 6.Medical Affairs Department, Nihon Servier KK, 7.Department of Medical Oncology, Kyorin University)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password